aVenture is in Alpha: aVenture recently launched early public access to our research product. It's intended to illustrate capabilities and gather feedback from users. While in Alpha, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to temporarily present this information to showcase the product's potential, but you should not yet rely upon it for your investment decisions.
aVenture is in Alpha: aVenture recently launched early public access to our research product. It's intended to illustrate capabilities and gather feedback from users. While in Alpha, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to temporarily present this information to showcase the product's potential, but you should not yet rely upon it for your investment decisions.
© aVenture Investment Company, 2025. All rights reserved.
44 Tehama St, San Francisco, CA 94105
Privacy Policy
aVenture Investment Company ("aVenture") is an independent venture capital research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals.
While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision.
aVenture does not offer investment advisory services and is not registered as an investment adviser. The data provided by aVenture does not constitute recommendations or advice, whether by methodology or a statement written by a staff member of aVenture.
Links to external websites do not imply endorsement or affiliation with aVenture. References or links to providers offering the ability to invest in a primary or secondary transaction in a company are for convenience purposes only. They are not solicitations or offers to buy or sell an investment. Remember that past performance does not guarantee future results, and venture capital and private assets should be a contributory part of a diversified portfolio.
Onconova Therapeutics, Inc. is a clinical-stage biopharmaceutical company dedicated to discovering and developing novel small molecule drug candidates to treat cancer. Based in Newtown, United States, the company aims to pioneer innovative cancer treatments, addressing unmet medical needs in oncology.
Onconova Therapeutics has made significant strides in cancer research, contributing to the development of promising therapeutic candidates. The company's impact is underscored by its commitment to advancing oncology treatments and improving patient outcomes.
Operating Status
Active
Ownership Type(s)
Public
Main Product(s)
Cancer Treatments
Technology
Biotech
Tags
Healthtech
Model Types
Software
Revenue Type(s)
Recurring
Customer Type(s)
Enterprise
Geographic Exposure
United States
When was Onconova Therapeutics founded?
Onconova Therapeutics was founded in 1998.
Where is Onconova Therapeutics’s headquarters located?
Onconova Therapeutics’s headquarters is located in Newtown, PA, US.
When was Onconova Therapeutics’s last funding round?
Onconova Therapeutics’s most recent funding round was for $21M (USD) in September 2021.
How many employees does Onconova Therapeutics have?
Onconova Therapeutics has 17 employees as of Feb 6, 2024.
How much has Onconova Therapeutics raised to-date?
As of July 05, 2023, Onconova Therapeutics has raised a total of $177.9M (USD) since Sep 24, 2021.
Add Comparison
Total Raised to Date
$177.9M
USD
Last Update Sep 24, 2021
Last Deal Details
$21M
USD
Sep 24, 2021
Post Ipo Equity
Total Employees Over Time
17
As of Feb 2024
Onconova Therapeutics Address
375 Pheasant Run
Newtown,
Pennsylvania
18940
United States
Source(s): This page includes data and analysis provided by the company, OpenAI, and our research analysts